Pharmaceuticals, Biotechnology and Life Sciences
Filing of the 2021 U.S. Form 20-F and French “Document d’Enregistrement Universel” containing the Annual Financial Report Paris, February 23,…
TOKYO and XIAMEN, China, Feb. 23, 2022 (GLOBE NEWSWIRE) — Riken Genesis Co., Ltd., Amoy Diagnostics Co., Ltd., (“AmoyDx”) and…
LYON, France, Feb. 23, 2022 (GLOBE NEWSWIRE) — Adocia (Euronext Paris: FR0011184241 – ADOC), a clinical-stage biopharmaceutical company specialized in…
October – December Net sales amounted to 2.4 (0.3) MSEKThe operating result for the period was -8.9 (-12.5) MSEKThe net…
MALVERN, Pa., Feb. 22, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (Nasdaq: OCGN), a clinical-stage biopharmaceutical company focused on discovering, developing,…
Montrouge, France, February 22, 2022 DBV Technologies to Participate in Upcoming AAAAI 2022 Congress DBV Technologies (Euronext: DBV – ISIN:…
MALVERN, Pa., Feb. 22, 2022 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on…
ROCKVILLE, Md., Feb. 22, 2022 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and…
SPARTA, N.J., Feb. 22, 2022 (GLOBE NEWSWIRE) — PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”) is a commercial-stage drug…
RALEIGH, N.C., Feb. 22, 2022 (GLOBE NEWSWIRE) — Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection…